AARD News

AARD LAWSUIT ALERT: Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. Investors - Lead Plaintiff Deadline October 13, 2026

Class Action Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of October 13, 2026 Deadline

Class Action Alert: Levi & Korsinsky Reminds Aardvark Therapeutics, Inc. (AARD) Investors of October 13, 2026 Deadline

AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

Pomerantz LLP Files Class Action Against Aardvark Therapeutics, Inc. – AARD

AARD Investor Notice: Hagens Berman Alerts Investors in Aardvark Therapeutics (NASDAQ: AARD) to Filing of Securities Fraud Class Action

DEADLINE ALERT for AARD, SMPL, ALAR, BABA: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

DEADLINE ALERT for HDB, SMPL, and AARD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders